Willard J. Costain

Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier

Danica Stanimirovic, Jagdeep K. Sandhu, Willard J. Costain · BioDrugs · 2018 · 103 citations · Full text

Pharmacy, Biotechnology, Pharmaceutics +17

Brain penetration, target engagement, and disposition of the blood‐brain barrier‐crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1

Carl I. Webster, Nadia L. Caram‐Salas, Arsalan S. Haqqani et al. · The FASEB Journal · 2016 · 80 citations

Pharmacy, Neuroscience, Pharmacology +17

DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations

Susan Crocker, Willard J. Costain, H.A. Robertson · Brain Research · 2006 · 54 citations

Life Sciences, Genetics, Neuroscience +14

Modulation of Agonist Binding to Human Dopamine Receptor Subtypes by l-Prolyl-l-leucyl-glycinamide and a Peptidomimetic Analog

Vaneeta Verma, Amandeep Mann, Willard J. Costain et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 49 citations

Medicine, Neuroscience, Pharmacology +17

Design, Synthesis, and Dopamine Receptor Modulating Activity of Diketopiperazine Peptidomimetics of<scp>l</scp>-Prolyl-<scp>l</scp>-leucylglycinamide

Paul W. Baures, W.H. Ojala, Willard J. Costain et al. · Journal of Medicinal Chemistry · 1997 · 43 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17